| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/29/2008 | US7323487 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 01/29/2008 | US7323486 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 01/29/2008 | US7323485 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 01/29/2008 | US7323484 Farnesyl transferase inhibitors |
| 01/29/2008 | US7323483 Processes and compounds for the preparation of substituted naphthylindole derivatives |
| 01/29/2008 | US7323482 Therapy of p38 kinase-associated conditions; may be useful in treating inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure |
| 01/29/2008 | US7323481 Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth |
| 01/29/2008 | US7323480 Diseases mediated by Peroxisome Proliferator-Activated Receptors such as glucose metabolism, lipid metabolism and insulin secretion, specifically Type 2 diabetes, hyperinsulemia, hyperlipidemia, hyperuricemia, hypercholesteremia, atherosclerosis, risk factors for cardiovascular disease, Syndrome X |
| 01/29/2008 | US7323479 Immunomodulators; side effect reduction |
| 01/29/2008 | US7323478 Phenylcycloalkylmethylamino and phenylalkenylamino derivatives, including 1-phenyl-2-aminomethylcyclopropanes; therapy of metabolic, feeding, and sexual disorders including obesity |
| 01/29/2008 | US7323477 alpha2 adrenergic receptor agonist; inhibit secretion of epinephrine and norepinephrine; analgesic; chronic neuropathic and visceral pain; treatment of glaucoma or ocular hypertension; side effect reduction (as hypotension and sedation) |
| 01/29/2008 | US7323476 Inhibitors of nuclear factor kappa B (NF- kappa B) and inhibit the activity of the endothelin receptor; inhibit cell proliferation and for the induction of apoptosis |
| 01/29/2008 | US7323475 Adjust concentration of erythropoietin in blood; strokes; antiepileptic agents; liver disorders; antiulcer agents; central nervous system disorders |
| 01/29/2008 | US7323474 Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase |
| 01/29/2008 | US7323473 Administering (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C) for treatment of obesity |
| 01/29/2008 | US7323472 Antiarthritic agents; sepsis shock; malaria; antiischemic agents; respiratory system disorders; brain disorders; congestive heart failure |
| 01/29/2008 | US7323471 Administering azathioprine, 6-mercaptopurine, or 6-thioguanine nucleotide, or their salts for treating graft-versus-host disease of the mouth; oral rinse |
| 01/29/2008 | US7323470 2-Heterocyclyl- indole, pyrrolopyridine, pyrrolopyrimidine, or pyrrolopirazine substituted with an N-(amino)sulfonyl(thio)carboxamide: 3-Cyclohexyl-2-furan-3-yl-7-methyl-1H-indole-6-(N-methylsulfonyl)carboxamide; treating a hepatitis virus infection |
| 01/29/2008 | US7323469 tyrosine kinase inhibitors; for the treatment especially of a proliferative disease, such as a tumor |
| 01/29/2008 | US7323468 as modulators of receptor tyrosine kinases and cytoplasmic tyrosine and serine/threonine kinases; can bind both to active and also to non-active kinases and therefore influence the signal transduction |
| 01/29/2008 | US7323467 3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| 01/29/2008 | US7323466 Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity |
| 01/29/2008 | US7323465 Alkansulfonamides as endothelin antagonists |
| 01/29/2008 | US7323464 Kinase inhibitors; autoimmune disease; antiinflammatory agents |
| 01/29/2008 | US7323463 Combination of brimonidine and timolol for topical ophthalmic use |
| 01/29/2008 | US7323461 Use of methylene blue and related compounds to prevent or reverse an exaggerated hemodynamic reaction |
| 01/29/2008 | US7323460 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as HIV integrase inhibitors |
| 01/29/2008 | US7323459 Dissolving olanzapine in a solution of acetic acid and water; filtering the solution; stirring the solution; precipitating the crystalline form by adding a base; and isolating the crystals |
| 01/29/2008 | US7323458 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 01/29/2008 | US7323457 Containing a perhydro-4-benzodiazepinylphenyl group 1-substituted with a methylaminoacetyl-, 4-piperidinylcarbonyl- or 2-pyrrolidinylcarbonyl- group: 4-(Piperidin-4-yl)carbonyl-1-{[2-(2-benzofuranoyl)amino]-4-[1-aminocarbonyl-2-(2-naphthyl)ethylamino]carbonylaminophenyl}homopiperazine; osteoporosis |
| 01/29/2008 | US7323456 Carboxylic acid derivatives compounds and agents comprising the compounds as active ingredient |
| 01/29/2008 | US7323455 1,2,3,5-Tetrahydro-4,1-benzoxazepine derivatives: 4-methyl-5-(5-methyl-2-oxo-5-phenyl-1,2,3,5-tetrahydro-4,1-benzoxazepin-7-yl)thiophene-2-carbonitrile; contraceptives; hormone replacement therapy |
| 01/29/2008 | US7323454 Etonogestrel undecanoate, decanoate and/or dodecanoate; male and female contraception and hormone replacement therapy; endometriosis, menorrhagia, meno-metrorrhagia, pre-menstrual syndrome and dysmenorrhoea |
| 01/29/2008 | US7323453 Administering substituted (beta -D-ribofuranosyl)purines or (beta -D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidines alone or incombination with cidofovir, ribavirin, levovirin, or viramidine, particularly against vaccinia virus or variola virus infections |
| 01/29/2008 | US7323452 Method for the accelerated in vivo removal of ethanol |
| 01/29/2008 | US7323451 Crystalline and amorphous forms of beta-L-2′-deoxythymidine |
| 01/29/2008 | US7323450 Combination of plasmids producing Th1 cytokines that activate NK cells and Th2 cytokines that antagonize TGF- beta inhibiting NK cells to disable immune system inhibition; canine transmissible venereal tumor |
| 01/29/2008 | US7323449 1-(2-(Hydroxymethyl)-5-thiolanyl)pyrrolo[2.3d]pyrimidine derivatives or their phosphates: 4-amino-7-(2-C-methyl-4-thio- beta -D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine; hepatitis C virus |
| 01/29/2008 | US7323448 Antibacterial agents |
| 01/29/2008 | US7323439 Methods and compositions for modulating angiogenesis |
| 01/29/2008 | US7323433 R-(-)-1-[2-(7-chlorobenzo[b]thiopen-3-yl-methoxy)-2-(2,4-dichlorophenyl)-ethyl]-1H-imidazole |
| 01/29/2008 | US7323340 Compositions and methods for regulating bacterial pathogenesis |
| 01/29/2008 | US7323316 Glycosyltransferase inhibitors |
| 01/29/2008 | US7323297 Stabilized polynucleotide complexes and methods |
| 01/29/2008 | US7323195 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 01/29/2008 | US7323191 Transdermal warfarin system |
| 01/29/2008 | US7323186 Non-absorbent articles containing additives |
| 01/29/2008 | US7323185 Topically applying a mixture of peroxide and a transitional metal to increase the efficacy of the peroxide in acne and skin disorder treatment |
| 01/29/2008 | US7323183 Vaccine compositions including chitosan for intranasal administration and use thereof |
| 01/29/2008 | US7323168 Immunotherapy for chronic myelocytic leukemia |
| 01/29/2008 | US7323164 Can be administered in conjunction with radiation or chemotherapeutic agents. |
| 01/29/2008 | US7323163 Film-forming compositions and methods |
| 01/29/2008 | US7322965 Infection-resistant medical devices |
| 01/29/2008 | CA2505930C Use of botulinum toxin in the preparation of a pharmaceutical composition for treating urinary retention |
| 01/29/2008 | CA2505487C Levobupivacaine and its use as an anaesthetic in obstetrics |
| 01/29/2008 | CA2471775C Targeted cytotoxic anthracycline analogs |
| 01/29/2008 | CA2451851C Use of pigment such as e.g. titanium dioxide for obtaining a special optical effect on oral medicament or food |
| 01/29/2008 | CA2438188C Modulated release particles for aerosol delivery |
| 01/29/2008 | CA2436540C Pharmaceutical compositions based on anticholinergics and corticosteroids |
| 01/29/2008 | CA2424029C Coated medical devices |
| 01/29/2008 | CA2417607C Lipase inhibitors for the treatment of dyspepsia |
| 01/29/2008 | CA2403349C Preparation of particles for inhalation |
| 01/29/2008 | CA2398485C Azalide antibiotic compositions |
| 01/29/2008 | CA2393057C Process for recovering pravastatin from a fermentation broth |
| 01/29/2008 | CA2385415C Compositions for regulating desire for smoking |
| 01/29/2008 | CA2383298C New amino acids, their preparation process and pharmaceutical compositions that contain these amino acids |
| 01/29/2008 | CA2345484C Hemostatic agent, method and carrier for applying a blood clotting agent |
| 01/29/2008 | CA2342634C Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative |
| 01/29/2008 | CA2336650C Medical device with porous surface for controlled drug release and method of making the same |
| 01/29/2008 | CA2333682C Cyclophosphamide film-coated tablets |
| 01/29/2008 | CA2323458C Metal chelators for use in the treatment of alzheimer's disease |
| 01/29/2008 | CA2315696C Pharmaceutical composition for oral administration |
| 01/29/2008 | CA2314170C Method of the prophylactic treatment of mastitis |
| 01/29/2008 | CA2312885C 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof |
| 01/29/2008 | CA2311423C Method for treating hyperlipidemia |
| 01/29/2008 | CA2311128C Composition with azelaic acid |
| 01/29/2008 | CA2297417C Derivatives of acyl-piperazinyl-pyrimidines, their preparation and application as medicaments |
| 01/29/2008 | CA2296720C Use of botulinum toxin in the preparation of a pharmaceutical composition for treating a prostate disorder in a mammal |
| 01/29/2008 | CA2294347C Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase |
| 01/29/2008 | CA2290446C Method and compositions for administering taxanes orally to human patients |
| 01/29/2008 | CA2285985C A method for preparing aqueous liposomal compositions comprising an active ingredient which is highly insoluble in water |
| 01/29/2008 | CA2266393C Aqueous antimicrobial liquid cleaning formulation comprising a polymeric deposition aid |
| 01/29/2008 | CA2263972C 6-o-substituted ketolides having antibacterial activity |
| 01/29/2008 | CA2262870C Liposome-based topical vitamin d formulation |
| 01/29/2008 | CA2256336C Quinolinomorphinan derivative and medical use thereof |
| 01/29/2008 | CA2255620C Novel anandamide amidase inhibitors as analgesic agents |
| 01/29/2008 | CA2251982C Ophthalmic compound with extended dwell time on the eye |
| 01/29/2008 | CA2237721C Antineoplastic peptides |
| 01/29/2008 | CA2236237C Use of hyaluronic acid and corresponding salts for the preparation of an aqueous solution useful as intra-articular lavage liquid |
| 01/29/2008 | CA2232989C 1,2,4-benzotriazine oxides formulations |
| 01/29/2008 | CA2226058C 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives |
| 01/29/2008 | CA2215682C 10-deacetylbaccatine iii and 10-deacetyl 14.beta.-hydroxybaccatine iii derivatives, a process for the preparation thereof and pharmaceutical compositions containing them |
| 01/29/2008 | CA2172886C Maltitol composition and process for preparing the same |
| 01/29/2008 | CA2149776C Use of methioninase as an antitumor agent in anti-methionine chemotherapy |
| 01/29/2008 | CA2142998C N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors |
| 01/29/2008 | CA2140928C Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/29/2008 | CA2136120C Treatment of incontinence |
| 01/29/2008 | CA2093808C Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 01/28/2008 | CA2613172A1 Nutritional formulations containing octenyl succinate anhydride-modified tapioca starch |
| 01/27/2008 | CA2594270A1 Antimicrobial hand wash |